Oruka Therapeutics, Inc. ($ORKA)
Filing Information
| Accession Number | 0000907654-26-000017 |
|---|---|
| Form Type | 4 |
| Filing Date | Jan 23, 2026 |
| Document Date | Jan 23, 2026 |
| Document | View SEC Filing |
Transactions
2
Total Shares
162,500
Total Value
$0.00
P&L
+inf% (+$6,712,875.00)
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Operating Officer | Common Stock | โ | Jan 23, 2026 | Grant/Award | 32,500 | $0.00 | $0.00 | 237,584 | Direct | โ | View Details | |
Chief Operating Officer | Employee Stock Option (right to buy) | Derivative | Jan 23, 2026 | Grant/Award | 130,000 | $0.00 | $0.00 | 130,000 | Direct | โ | View Details |